FDA authorizes Pfizer's pill to treat COVID-19: 'A major step forward'


The Food and Drug Administration has officially authorized the first antiviral pill to treat COVID-19 in the United States.
The FDA announced Wednesday it has approved Paxlovid, an oral antiviral COVID-19 treatment from Pfizer, for emergency use to treat mild-to-moderate COVID-19 for patients at "at high risk for progression to severe" COVID-19.
"Today's authorization introduces the first treatment for COVID-19 that is in the form of a pill that is taken orally — a major step forward in the fight against this global pandemic," said Dr. Patrizia Cavazzoni, director of the FDA Center for Drug Evaluation and Research. "This authorization provides a new tool to combat COVID-19 at a crucial time in the pandemic as new variants emerge and promises to make antiviral treatment more accessible to patients who are at high risk for progression to severe COVID-19."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Pfizer previously announced that the antiviral pill in a trial reduced the risk of hospitalization or death among high-risk COVID-19 patients by 89 percent when it was given within three days of symptoms first emerging. "It is a game changer," Pfizer CEO Albert Bourla told ABC News. "But at the same time, I want to emphasize that no one should use the existence of the pill as an excuse to avoid vaccination." The FDA in its Wednesday announcement also noted that the pill "is not a substitute for vaccination."
Another COVID-19 pill could soon be authorized by the FDA, as well, as Bloomberg reported that an antiviral pill from Merck could receive approval this week.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
El Palace Barcelona: old-world luxury in the heart of the city
The Week Recommends This historic hotel is set within a former Ritz outpost moments from the Passeig de Gràcia
-
The best history books to read in 2025
The Week Recommends These fascinating deep-dives are perfect for history buffs
-
July 4 editorial cartoons
Cartoons Friday’s political cartoons include the danger of talking politics at a family picnic, and disappearing Medicaid entitlements
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr.: A new plan for sabotaging vaccines
Feature The Health Secretary announced changes to vaccine testing and asks Americans to 'do your own research'
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths